The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

White Papers
Clinical-Supply Integration: Accelerating Performance
Explore your organization’s clinical integration maturity and leverage leadership involvement to make data-driven decisions.
White Papers
Supply Chain Integration of Merged and Acquired Entities
This paper shares the experience of a true and complete integration of supply chain in a mid-sized IDN under an accelerated timeline. The stud
Press Releases
In Partnership with AHRMM, Institute for Supply Management® Expands Portfolio of Economic Reports with Launch of Hospital PMI™
CHICAGO, July 23, 2020 — In partnership with the Association for Health Care Resource & Materials Management (AHRMM) of the American Hospital A
Guides/Reports
Hospital ISM® Report On Business®
On-Demand Educational Webinars
Supply Chain's Role in Non-Labor Expense Management (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)
Supply chain leaders share their processes and experiences in managing non-labor and non-personnel expenses.
On-Demand Educational Webinars
The Provider Perspective on Building Supply Chain Resiliency (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)
Provider panelists discuss their post-pandemic approach to their business continuity programs, working with non-traditional buyers, diversifying…